Table 1.
Compositions of liposomes used with corresponding abbreviations
| PC:Ch:Rh-PE | LIP |
| PC:Ch:Rh-PE:NGPE + TAT-peptide | LIP-NGPE-TAT |
| PC:Ch:Rh-PE:PEG(2000)-PE(5% mol) | LIP-PEG(2000) |
| PC:Ch:Rh-PE:PEG(5000)-PE(5% mol) | LIP-PEG(5000) |
| PC:Ch:Rh-PE:pNP-PEG(3000)-PE(0.5% mol) | LIP-pNP-PEG(3000) |
| PC:Ch:Rh-PE:pNP-PEG(3000)-PE(0.5% mol) + TAT-peptide | LIP-pNP-PEG(3000)-TAT |
| PC:Ch:Rh-PE:PEG(2000)-PE(4.5% mol):pNP-PEG(3000)-PE(0.5% mol) + TAT-peptide | LIP-PEG(2000)/pNP-PEG(3000)-TAT |
| PC:Ch:Rh-PE:PEG(5000)-PE(4.5% mol):pNP-PEG(3000)-PE(0.5% mol) + TAT-peptide | LIP-PEG(5000)/pNP-PEG(3000)-TAT |
| PC:Ch:Rh-PE:pNP-PEG(3000)-PE(0.5% mol) + TAT-peptide (+ FITC-dextran) | LIP-pNP-PEG(3000)-TAT/FITC-dextran |